The Madigan Army Medical Center, located on Joint Base Lewis-McChord just outside Lakewood, Washington, is a key component of the Madigan Healthcare System and one of the largest military hospitals on the West Coast of the United States.

There are 205 beds in Madigan Army Medical Center.

During the past decade, Madigan Army Medical Center conducted 90 clinical trials. In the 10-year time frame, 90 clinical trials started and 81 clinical trials were completed, i.e. on average, 90% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 38 clinical trials were completed. i.e. 115.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Madigan Army Medical Center" #1 sponsor was "Children's Oncology Group" with 101 trials, followed by "National Cancer Institute (NCI)" with 51 trials sponsored, "SWOG Cancer Research Network" with 44 trials sponsored, "Madigan Army Medical Center" with 16 trials sponsored and "Alliance for Clinical Trials in Oncology" with 16 trials sponsored. Other sponsors include 101 different institutions and companies that sponsored additional 70 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Madigan Army Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 179 trials as a collaborator, "Madigan Army Medical Center" with 18 trials as a collaborator, "SWOG Cancer Research Network" with 16 trials as a collaborator, "Cancer and Leukemia Group B" with 13 trials as a collaborator and "NCIC Clinical Trials Group" with 10 trials as a collaborator. Other collaborators include 133 different institutions and companies that were collaborators in the rest 82 trials.

According to Clinical.Site data, the most researched conditions in "Madigan Army Medical Center" are "Leukemia" (25 trials), "Prostate Cancer" (16 trials), "Recurrent Neuroblastoma" (16 trials), "Breast Cancer" (15 trials) and "Refractory Neuroblastoma" (15 trials). Many other conditions were trialed in "Madigan Army Medical Center" in a lesser frequency.

Most popular intervention types in "Madigan Army Medical Center" are "Drug" (239 trials), "Other" (100 trials), "Procedure" (82 trials), "Biological" (78 trials) and "Radiation" (66 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (50 trials), "Cyclophosphamide" (33 trials), "cyclophosphamide" (32 trials), "Vincristine Sulfate" (30 trials) and "radiation therapy" (27 trials). Other intervention names were less common.

The vast majority of trials in "Madigan Army Medical Center" are 278 trials for "All" genders, 32 trials for "Female" genders and 21 trials for "Male" genders.

Currently, there are NaN active trials in "Madigan Army Medical Center". 1 are not yet recruiting, 46 are recruiting, 58 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 183 completed trials in Madigan Army Medical Center, 2 suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Madigan Army Medical Center, 9 "Phase 1" clinical trials were conducted, 97 "Phase 2" clinical trials and 144 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 40 trials that are defined as “Not Applicable".